Abstract
The pharmacokinetic characteristics of rufinamide are described and the interaction effects of concomitant antiepileptic drugs on rufinamide in terms of its pharmacokinetics and pharmacodynamics are highlighted.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Perucca E, Cloyd J, Critchley D, Fuseau E. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia. 2008;49:1123–41.
Brodie MJ, Rosenfeld WE, Vazquez B, et al. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents a randomized placebo-controlled trial. Epilepsia. 2009;50:1899–909.
May TW, Boor R, Rambeck B, Jurgens U, Korn-Merker E, Brandt C. Serum concentrations of rufinamide in children and adults with epilepsy the influence of dose, age, and comedication. Ther Drug Monit. 2011;33:214–21.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Patsalos, P.N. (2016). Rufinamide. In: Antiepileptic Drug Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-32909-3_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-32909-3_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32908-6
Online ISBN: 978-3-319-32909-3
eBook Packages: MedicineMedicine (R0)